Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Revenue

Viridian Therapeutics had revenue of $86.00K in the quarter ending September 30, 2024, with 19.44% growth. This brings the company's revenue in the last twelve months to $302.00K, down -12.97% year-over-year. In the year 2023, Viridian Therapeutics had annual revenue of $314.00K, down -82.28%.

• Revenue (ttm): $302.00K
• Revenue Growth: -12.97%
• P/S Ratio: n/a
• Revenue / Employee: $3,213
• Employees: 94
• Market Cap: 1.61B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	314.00K	-1.46M	-82.28%
Dec 31, 2022	1.77M	-1.19M	-40.20%
Dec 31, 2021	2.96M	1.91M	182.19%
Dec 31, 2020	1.05M	-3.41M	-76.46%
Dec 31, 2019	4.46M	-3.92M	-46.80%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.